Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID Study of rapid intraoperative iron polymaltose infusion
ACTRN12613000356763Phase 4Completed
- Sponsor
- Dr Roger M Browning
- Start
- Jul 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iron polymaltose in iron deficiency anemia (IDA) and anaemia, sponsored by Dr Roger M Browning. Primary endpoints: Incidence of significant hypotension during and after iron infusion and Incidence of significant low blood pressure following administration of iron polymaltose. Started Jul 2013; status: completed.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)anaemia
Beyond the preview
Go deeper on ACTRN12613000356763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000356763.